Physician profile
Jay R Mcdougal
NPI 1134402555
$1,435.94
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $663 · 2021: $148.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $264.79 | 2019-2020 | |
| Amgen INC. | $187.44 | 2019-2021 | |
| Pfizer INC. | $176.24 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $103.56 | 2019-2021 | |
| Lilly USA, LLC | $91.60 | 2019-2020 | |
| Novo Nordisk INC | $89.19 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $77.74 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.39 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.72 | 2020 | |
| Ironshore Pharmaceuticals INC. | $42.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.60 | 2019 | |
| Glaxosmithkline, LLC. | $34.52 | 2019-2020 | |
| Astellas Pharma US INC | $26.96 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.82 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $20.28 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.71 | 2019 | |
| Shire North American Group INC | $14.42 | 2019 | |
| Ethicon US, LLC | $13.72 | 2019 | |
| Quidel Corporation | $13.57 | 2019 | |
| Amarin Pharma, INC. | $12.45 | 2019 | |
| Biodelivery Sciences International, INC. | $11.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Mcdougal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.